{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:43:07Z","timestamp":1792651387271,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.puhe.2022.09.001","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T02:05:58Z","timestamp":1662602758000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-9629","authenticated-orcid":false,"given":"K.I.P.","family":"Prabani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-5057","authenticated-orcid":false,"given":"I.","family":"Weerasekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.D.W.T.","family":"Damayanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2022.09.001_bib1","unstructured":"National Comprehensive Cancer Network. Recommendations of the NCCN COVID-19 vaccination advisory committee, https:\/\/www.nccn.org\/docs\/default-source\/covid-19\/2021_covid-19_vaccination_guidance_v2-0.pdf 2021 [cited 2021 19th June]."},{"key":"10.1016\/j.puhe.2022.09.001_bib2","series-title":"COVID-19 vaccination guide for people with cancer","year":"2021"},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaccao.2020.03.001","article-title":"The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer","volume":"2","author":"Ganatra","year":"2020","journal-title":"JACC CardioOncology"},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/2159-8290.CD-20-1817","article-title":"Priority covid-19 vaccination for patients with cancer while vaccine supply is limited","volume":"11","author":"Ribas","year":"2021","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jnci\/djab174","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients","volume":"114","author":"Ligumsky","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.puhe.2022.09.001_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9091048","article-title":"Covid-19 vaccines in cancer patients. Seropositivity and safety. systematic review and meta-analysis","volume":"9","author":"Cavanna","year":"2021","journal-title":"Vaccines"},{"issue":"14","key":"10.1016\/j.puhe.2022.09.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13143573","article-title":"Covid-19 vaccine safety in cancer patients: a single centre experience","volume":"13","author":"So","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.puhe.2022.09.001_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1470-2045(21)00213-8","article-title":"Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study","volume":"22","author":"Monin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01046-w","article-title":"COVID-19 vaccines for patients with cancer: benefits likely outweigh risks","volume":"14","author":"Hwang","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-021-00487-z","article-title":"COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials","volume":"18","author":"Desai","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jebm.12266","article-title":"Gray literature: an important resource in systematic reviews","volume":"10","author":"Paez","year":"2017","journal-title":"J\u00a0Evid Base Med"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib12","first-page":"1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2022.09.001_bib13","unstructured":"Joanna Briggs Institute. Critical appraisal tools | Joanna briggs Institute. Joanna Briggs Institute (JBI). 3rd June 2021. https:\/\/jbi.global\/critical-appraisal-tools."},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s13187-019-01548-9","article-title":"Managing pain in people with cancer-a systematic review of the attitudes and knowledge of Professionals, Patients, Caregivers and Public","volume":"35","author":"Makhlouf","year":"2020","journal-title":"J\u00a0Cancer Educ"},{"key":"10.1016\/j.puhe.2022.09.001_bib15","unstructured":"Age categories in late adulthood | Lifespan Development, https:\/\/courses.lumenlearning.com\/suny-lifespandevelopment\/chapter\/age-categories-in-late-adulthood\/[accessed 12 Feb 2022]."},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib16","first-page":"183","article-title":"Classification of age groups based on facial features","volume":"4","author":"Horng","year":"2001","journal-title":"Tamkang J Sci Eng"},{"issue":"8","key":"10.1016\/j.puhe.2022.09.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9080900","article-title":"Long-term impact of COVID-19: a systematic review of the literature and meta-analysis","volume":"9","author":"Sanchez-Ramirez","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.puhe.2022.09.001_bib18","unstructured":"Deeks JJ, Higgins JPT AD (editors). 9.5.2 Identifying and measuring heterogeneity. [Chapter 9] Sect Anal data Undert meta-analyses 952 Higgins JPT, Green S (editors) Cochrane interv handb syst rev Cochrane, Version 502 (updated Sept 2009) Collab 2009, https:\/\/handbook-5-1.cochrane.org\/chapter_9\/9_5_2_identifying_and_measuring_heterogeneity.htm 2009 [accessed 07th July 2022]."},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejvs.2015.11.010","article-title":"Quick guide to systematic reviews and meta-analysis","volume":"51","author":"Koelemay","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.puhe.2022.09.001_bib20","first-page":"1","article-title":"COVID-19 vaccine development from the perspective of cancer patients","author":"He","year":"2021","journal-title":"Hum Vaccines Immunother"},{"issue":"31","key":"10.1016\/j.puhe.2022.09.001_bib21","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2217\/fon-2021-0265","article-title":"Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey","volume":"17","author":"Moujaess","year":"2021","journal-title":"Future Oncol"},{"issue":"12","key":"10.1016\/j.puhe.2022.09.001_bib22","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1080\/21645515.2021.1992212","article-title":"Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients","volume":"17","author":"Zhuang","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.puhe.2022.09.001_bib23","first-page":"1","article-title":"Drivers of COVID-19 vaccine intent among survivors of adolescent and young adult cancer: a mixed method study","author":"Waters","year":"2022","journal-title":"J\u00a0Cancer Educ"},{"key":"10.1016\/j.puhe.2022.09.001_bib24","first-page":"1","article-title":"Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: a cross-sectional study","author":"Roupa","year":"2021","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.puhe.2022.09.001_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00432-022-03961-y","article-title":"Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: a cross-sectional survey","volume":"148","author":"Heyne","year":"2022","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.puhe.2022.09.001_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.breast.2021.10.012","article-title":"COVID-19 vaccination in patients with breast cancer and gynecological malignancies: a German perspective","volume":"60","author":"Forster","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.puhe.2022.09.001_bib27","series-title":"Acceptance , efficacy , and safety of COVID-19 vaccination in older patients with cancer","author":"laure","year":"2022"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib28","first-page":"4565","article-title":"Acceptance of SARS-CoV-2 vaccination among cancer patients in Portugal: attitudes and associated factors","volume":"30","author":"de Sousa","year":"2022","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.puhe.2022.09.001_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon-2021-1015","article-title":"Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: a single-center study","volume":"18","author":"Erdem","year":"2022","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.joim.2021.10.004","article-title":"Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey","volume":"20","author":"Hong","year":"2022","journal-title":"J\u00a0Integr Med"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/vaccines9050411","article-title":"Attitudes of patients with cancer towards vaccinations\u2014results of online survey with special focus on the vaccination against COVID-19","volume":"9","author":"Brodziak","year":"2021","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/crst.crst_138_21","article-title":"COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: a questionnaire-based survey","volume":"4","author":"Noronha","year":"2021","journal-title":"Cancer Res Stat Treat"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib33","first-page":"289","article-title":"Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients","volume":"30","author":"Mejri","year":"2021","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.puhe.2022.09.001_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9070792","article-title":"Acceptance of covid-19 vaccination in cancer patients in Hong Kong: approaches to improve the vaccination rate","volume":"9","author":"Chan","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.annonc.2021.01.066","article-title":"Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey","volume":"32","author":"Barri\u00e8re","year":"2021","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib36","first-page":"209","article-title":"Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer","volume":"71","author":"Villarreal-Garza","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.puhe.2022.09.001_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejca.2021.05.006","article-title":"The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey","volume":"153","author":"Di Noia","year":"2021","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jncics\/pkab049","article-title":"COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors","volume":"5","author":"Waters","year":"2021","journal-title":"JNCI Cancer Spectr"},{"issue":"15","key":"10.1016\/j.puhe.2022.09.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13153883","article-title":"Cancer patients' willingness to take covid-19 vaccination: a nationwide multicenter survey in korea","volume":"13","author":"Chun","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5603\/AHP.2021.0041","article-title":"COVID-19 vaccine hesitancy among lymphoma patients in Poland","volume":"52","author":"Brzuszek","year":"2021","journal-title":"Acta Haematol Pol"},{"key":"10.1016\/j.puhe.2022.09.001_bib41","series-title":"COVID-19 vaccine hesitancy among blood cancer patients","author":"Conti","year":"2021"},{"key":"10.1016\/j.puhe.2022.09.001_bib42","first-page":"1","article-title":"COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: a multicenter study","author":"Nguyen","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"11","key":"10.1016\/j.puhe.2022.09.001_bib43","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.31557\/APJCP.2021.22.11.3499","article-title":"COVID-19 vaccination acceptance and its associated factors among cancer patients in Tunisia","volume":"22","author":"Khiari","year":"2021","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.puhe.2022.09.001_bib44","first-page":"4865","article-title":"Knowledge and proportion of covid-19 vaccination and associated factors among cancer patients attending public hospitals of addis ababa, Ethiopia, 2021: a multicenter study","author":"Admasu","year":"202114","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.puhe.2022.09.001_bib45","first-page":"1","article-title":"Acceptance, effects, and tolerability in the vaccination process against SARS-CoV-2 virus among cancer patients in Bosnia and Herzegovina: a single-center cross-sectional study","author":"Ceric","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.puhe.2022.09.001_bib46","first-page":"1","article-title":"Prevalence and impact factors of COVID-19 vaccination hesitancy among breast cancer survivors: a multicenter cross-sectional study in China","author":"Peng","year":"20218","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib47","first-page":"2183","article-title":"COVID-19 vaccines and cancer patients: acceptance, attitudes and safety","volume":"26","author":"Brko","year":"2021","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.puhe.2022.09.001_bib48","first-page":"1","article-title":"Acceptance of COVID-19 vaccination and its associated factors among cancer patients attending the oncology clinic of university clinical hospital mostar, Bosnia and Herzegovina: a cross-sectional study","volume":"27","author":"Marijanovic","year":"2021","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"11","key":"10.1016\/j.puhe.2022.09.001_bib49","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.annonc.2021.07.012","article-title":"Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients","volume":"32","author":"Heudel","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.puhe.2022.09.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101113","article-title":"Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: a systematic review","volume":"40","author":"Cascini","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10010110","article-title":"Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors","volume":"10","author":"Shakeel","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.puhe.2022.09.001_bib52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/vaccines9080900","article-title":"Covid-19 vaccine hesitancy\u2014a scoping review of literature in high-income countries","volume":"9","author":"Aw","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.puhe.2022.09.001_bib53","first-page":"204","article-title":"Gender differences in the intention to get vaccinated against COVID-19 - a systematic review and meta-analysis","volume":"11","author":"Zintel1","year":"2020","journal-title":"J\u00a0Emerg Technol Innov Res"},{"issue":"5","key":"10.1016\/j.puhe.2022.09.001_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9050515","article-title":"Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries","volume":"9","author":"Bono","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.puhe.2022.09.001_bib55","article-title":"Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications","volume":"1","author":"Paul","year":"2021","journal-title":"Lancet Reg Heal - Eur."},{"issue":"1145","key":"10.1016\/j.puhe.2022.09.001_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/postgradmedj-2020-138903","article-title":"Will vaccination refusal prolong the war on SARS-CoV-2?","volume":"97","author":"Marcec","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.puhe.2022.09.001_bib57","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2147\/JMDH.S276771","article-title":"Determinants of covid-19 vaccine acceptance in Saudi Arabia: a web-based national survey","volume":"13","author":"Al-Mohaithef","year":"2020","journal-title":"J\u00a0Multidiscip Healthc"},{"issue":"10","key":"10.1016\/j.puhe.2022.09.001_bib58","article-title":"Messages that increase COVID-19 vaccine acceptance: evidence from online experiments in six Latin American countries. Delcea C","volume":"16","author":"Tironi","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines10030386","article-title":"The effectiveness of interventions for increasing COVID-19 vaccine uptake: a systematic review","volume":"10","author":"Batteux","year":"2022","journal-title":"Vaccines"},{"issue":"7876","key":"10.1016\/j.puhe.2022.09.001_bib60","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-021-03843-2","article-title":"Behavioural nudges increase COVID-19 vaccinations","volume":"597","author":"Dai","year":"2021","journal-title":"Nature"},{"issue":"June","key":"10.1016\/j.puhe.2022.09.001_bib61","article-title":"Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors","volume":"150","author":"Wang","year":"2021","journal-title":"Prev Med"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib62","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.pec.2011.03.022","article-title":"Education level, not health literacy, associated with information needs for patients with cancer","volume":"85","author":"Matsuyama","year":"2011","journal-title":"Patient Educ Counsel"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1743-7563.2012.01522.x","article-title":"Importance of health literacy in oncology","volume":"8","author":"Koay","year":"2012","journal-title":"Asia Pac J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.puhe.2022.09.001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100027","article-title":"Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey","volume":"6","author":"Gheorghe","year":"2021","journal-title":"ESMO Open"},{"issue":"40","key":"10.1016\/j.puhe.2022.09.001_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2108576118","article-title":"Trust in scientists in times of pandemic: panel evidence from 12 countries","volume":"118","author":"Algan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.puhe.2022.09.001_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3122\/jabfm.2022.02.210327","article-title":"Motivational interviewing strategies for addressing COVID-19 vaccine hesitancy","volume":"35","author":"Boness","year":"2022","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.puhe.2022.09.001_bib67","article-title":"Impact of an\u00a0education intervention on COVID-19 vaccine hesitancy in a military base\u00a0population","volume":"1\u20137","author":"Li","year":"2021","journal-title":"Mil Med"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/healthcare9030351","article-title":"Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar","volume":"9","author":"Kelkar","year":"2021","journal-title":"Healthc"},{"issue":"3","key":"10.1016\/j.puhe.2022.09.001_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare9030351","article-title":"Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar","volume":"9","author":"Kelkar","year":"2021","journal-title":"Healthc"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350622002566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350622002566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:39:34Z","timestamp":1758501574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350622002566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":69,"alternative-id":["S0033350622002566"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2022.09.001","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine acceptance and hesitancy among patients with cancer: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2022.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}